Jaspan J B, Huen A H, Morley C G, Moossa A R, Rubenstein A H
J Clin Invest. 1977 Aug;60(2):421-8. doi: 10.1172/JCI108791.
Total plasma immunoreactive pancreatic glucagon (IRG) was measured in samples taken simultaneously from the proximal portal vein and superior vena cava of 26 healthy rats. The portal-peripheral ratio of IRG was 2.80+/-0.25, the portal-peripheral difference (Delta) 124+/-15 pg/ml, and percentage extraction 58+/-3. Gel filtration of paired portal and peripheral vein samples showed that reduction in the 3,500-dalton IRG component (glucagon) in peripheral samples accounted for almost all the differences, there being minimal and inconsistent changes in the high molecular weight (>40,000) fraction. The portal-peripheral ratio of the 3,500-dalton glucagon was 5.24+/-1.10, the portal-peripheral difference 130+/-33 pg/ml, and the percentage extraction 81+/-5. To study the transhepatic differences in the 9,000-dalton "proglucagon-like" material, the experiment was repeated in nine rats 24 h after bilateral nephrectomy, a procedure which increases plasma levels of this fraction. The portal-peripheral ratio for plasma IRG in these rats was 1.48+/-0.12, the portal-peripheral difference 140+/-29 pg/ml, and percentage extraction 28+/-5. Gel filtration revealed no consistent differences between portal and peripheral concentrations of the 9,000- and >40,000-dalton components, which comprised 40 and 13%, respectively, of the mean IRG level of 492+/-35 pg/ml. In contrast, there were marked differences between portal and peripheral levels of the 3,500-dalton component the ratio being 3.42+/-0.63, the portal-peripheral difference 182+/-32 pg/ml, and percentage extraction 64+/-5. Similar studies in a healthy dog, in which species there are significant circulating levels of the 9,000-dalton IRG component, confirmed the selective hepatic extraction of the 3,500-dalton fraction. We conclude that the various IRG fractions are metabolized differently by the liver, and that portal-peripheral ratios based on direct assay of plasma IRG will vary depending on the percentage glucagon immunoreactivity in each fraction; the greater the combined contribution of fractions other than the 3,500-dalton component to total plasma IRG, the lower will be the ratio. Because of the heterogeneity of circulating IRG and significant differences in the metabolism of its various components, gel filtration of plasma samples is necessary for precise quantitation of the hepatic uptake of each particular fraction.
对26只健康大鼠同时从门静脉近端和上腔静脉采集的样本进行了血浆免疫反应性胰高血糖素(IRG)总量测定。IRG的门静脉-外周血比值为2.80±0.25,门静脉-外周血差值(Δ)为124±15 pg/ml,提取率为58±3。对配对的门静脉和外周静脉样本进行凝胶过滤显示,外周样本中3500道尔顿IRG成分(胰高血糖素)的减少几乎解释了所有差异,高分子量(>40000)部分的变化极小且不一致。3500道尔顿胰高血糖素的门静脉-外周血比值为5.24±1.10,门静脉-外周血差值为130±33 pg/ml,提取率为81±5。为研究9000道尔顿“胰高血糖素原样”物质的肝内差异,在9只大鼠双侧肾切除24小时后重复该实验,双侧肾切除可使该部分血浆水平升高。这些大鼠血浆IRG的门静脉-外周血比值为1.48±0.12,门静脉-外周血差值为140±29 pg/ml,提取率为28±5。凝胶过滤显示,9000道尔顿和>40000道尔顿成分的门静脉和外周血浓度之间没有一致的差异,这两种成分分别占平均IRG水平492±35 pg/ml的40%和13%。相比之下,3500道尔顿成分的门静脉和外周血水平存在显著差异,比值为3.42±0.63,门静脉-外周血差值为182±32 pg/ml,提取率为64±5。在一只健康犬身上进行的类似研究(该物种中9000道尔顿IRG成分有显著的循环水平)证实了肝脏对3500道尔顿部分的选择性摄取。我们得出结论,肝脏对各种IRG部分的代谢方式不同,基于血浆IRG直接测定的门静脉-外周血比值将因各部分中胰高血糖素免疫反应性的百分比而异;除3500道尔顿成分外的其他部分对总血浆IRG的综合贡献越大,比值就越低。由于循环IRG的异质性及其各种成分代谢的显著差异,对血浆样本进行凝胶过滤对于精确定量肝脏对每个特定部分的摄取是必要的。